pCMV5-rat ERK2-D319N Citations (1)

Originally described in: Constitutive activation of extracellular signal-regulated kinase 2 by synergistic point mutations.
Emrick MA, Hoofnagle AN, Miller AS, Ten Eyck LF, Ahn NG J Biol Chem. 2001 Dec 7;276(49):46469-79. Epub 2001 Oct 8. PubMed Journal

---

Articles Citing pCMV5-rat ERK2-D319N

Articles

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death. Virard F, Giraud S, Bonnet M, Magadoux L, Martin L, Pham TH, Skafi N, Deneuve S, Frem R, Villoutreix BO, Sleiman NH, Reboulet J, Merabet S, Chaptal V, Chaveroux C, Hussein N, Aznar N, Fenouil T, Treilleux I, Saintigny P, Ansieau S, Manie S, Lebecque S, Renno T, Coste I. Nat Commun. 2024 Aug 15;15(1):7037. doi: 10.1038/s41467-024-51275-z. PubMed

If you have published an article using this material, please email us at to have your article added to this page.